Vandoorslaert médecine aiguë financials
A multi-period view of the public annual-account figures reported for Vandoorslaert médecine aiguë, with comparable measures and links to available source documents.
Company overviewRegistry number
0630988067
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 29, 2026
Financial evidence
Latest movements for Vandoorslaert médecine aiguë
2025 versus 2024
- Operating line
- €82,706
- EBITDA
- €39,929
- Total assets
- €79,884
- Equity
- €37,691
+3.4%
+2.9%
-21.6%
+21%
EBITDA margin +48.3% · Equity ratio +47.2%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €82,706 | €39,929 | €79,884 | €37,691 | - |
| 202431 Dec 2024 | €79,960 | €38,801 | €101,837 | €31,146 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.